Cidara Therapeutics Stock Forecast

Stock Price Forecast

According to 6 professional analysts, the 12-month price target for Cidara Therapeutics stock ranges from a low of $34 to a high of $47. The average price target of $38.5 forecasts a 98.15% increase in the stock price over the next year.

Price Target: $38.50 (+98.15%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$34	$38.5	$35	$47
Change	+74.99%	+98.15%	+80.13%	+141.89%

Analyst Ratings

The average analyst rating for Cidara Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25	May '25
Strong Buy	4	4	4	4	4	4
Buy	2	3	3	4	4	4
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	7	7	8	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Seamus Fernandez Guggenheim	Guggenheim	Strong Buy Maintains $33 → $35	Strong Buy	Maintains	$33 → $35	+80.13%	May 9, 2025
Roy Buchanan JMP Securities	JMP Securities	Buy Maintains $46 → $47	Buy	Maintains	$46 → $47	+141.89%	May 9, 2025
Roy Buchanan JMP Securities	JMP Securities	Buy Reiterates $46	Buy	Reiterates	$46	+136.75%	Apr 29, 2025
Joseph Stringer Needham	Needham	Strong Buy Reiterates $35	Strong Buy	Reiterates	$35	+80.13%	Apr 10, 2025
Roy Buchanan Citizens Capital Markets	Citizens Capital Markets	Buy Initiates $46	Buy	Initiates	$46	+136.75%	Mar 12, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 1.28M

Revenue Next Year

n/a

EPS This Year

-10.40

from -26.75

EPS Next Year

-10.44

from -10.40

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	12.07M	49.57M	23.50M	23.28M	1.28M	-	-	6.63M
Revenue Growth	-42.31%	310.81%	-52.60%	-0.91%	-94.52%	-	-	-
EPS	-36.03	-16.20	-9.61	-5.25	-26.75	-10.40	-10.44	-9.85
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	9	8	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	n/a	34.1M
Avg	n/a	n/a	6.6M
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-5.71	-4.08	-3.22
Avg	-10.40	-10.44	-9.85
Low	-17.01	-14.35	-16.33

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.